About this Special Issue
Lung transplantation has made significant strides in the 21st century, with new technological developments and innovative approaches to care, improving outcomes for patients. In this Special Issue, we aim to bring together experts in the field to present the latest advancements and future prospects in the following areas:
The latest technological developments that can increase access to lung transplantation
- new approaches to organ allocation (i.e. Composite Allocation Score) and organ management (i.e. lung preservation techniques, ex vivo lung perfusion (EVLP), normothermic regional machine perfusion (NMP), and patient selection criteria;
Novel developments in organ tolerance, regeneration and repair, and precision medicine
- the latest research in tailored strategies for patient management, including HLA matching methodology, the use of stem cells, and other technologies for promoting tissue repair and regeneration;
- the use of digital technologies in the field of lung transplantation, including telemedicine, remote monitoring, monitoring of cell-free DNA, novel imaging techniques, and other innovative approaches;
- cutting edge strategies for personalized care and treatment, including the use of precision medicine and individualized immunosuppressive regimens;
Future prospects
- technologies which may improve patient outcomes in the near future, such as gene-editing, xenotransplantation, tissue engineering and biodegradable scaffolds
We warmly welcome submissions from both solicited and spontaneous submissions.
Deadlines
Abstract submission: 3rd April 2023
Manuscript submission: 15th December 2023
Important
As a Gold open access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.
Please see the following pages for:
Publishing Fees
Author Guidelines
The latest technological developments that can increase access to lung transplantation
- new approaches to organ allocation (i.e. Composite Allocation Score) and organ management (i.e. lung preservation techniques, ex vivo lung perfusion (EVLP), normothermic regional machine perfusion (NMP), and patient selection criteria;
Novel developments in organ tolerance, regeneration and repair, and precision medicine
- the latest research in tailored strategies for patient management, including HLA matching methodology, the use of stem cells, and other technologies for promoting tissue repair and regeneration;
- the use of digital technologies in the field of lung transplantation, including telemedicine, remote monitoring, monitoring of cell-free DNA, novel imaging techniques, and other innovative approaches;
- cutting edge strategies for personalized care and treatment, including the use of precision medicine and individualized immunosuppressive regimens;
Future prospects
- technologies which may improve patient outcomes in the near future, such as gene-editing, xenotransplantation, tissue engineering and biodegradable scaffolds
We warmly welcome submissions from both solicited and spontaneous submissions.
Deadlines
Abstract submission: 3rd April 2023
Manuscript submission: 15th December 2023
Important
As a Gold open access journal, all submissions are subject to publishing fees. Fee solutions are available on a case-by-case basis, including discounts for ESOT members, Institutional Agreements, and authors from low- and middle-income countries. Please contact the editorial office if you have any questions: ti@frontierspartnerships.org.
Please see the following pages for:
Publishing Fees
Author Guidelines
Keywords: lung transplantation, organ allocation, HLA matching, precision medicine, organ management, gene-editing, xenotransplantation, tissue engineering, biodegradable scaffolds, stem cells, telemedicine, perfusion, ex vivo lung perfusion
